Clarapath
Hawthorne, US · Delaware corporation · 3 known investors
Clarapath develops SectionStar, an automated tissue sectioning system for histology laboratories that aims to improve slide quality, reduce turnaround time and lower costs. The company builds healthcare robotics for laboratory medicine and pathology workflows.
Also known as Clarapath
Founders & leadership
Board
Investors · 3
Funding
SEC filings, press & company announcements$40.2M disclosed across 2 of 5 rounds · 2019–2024
▶$36MraisedJul 2024 · 39 investors · Other Health CareRule 506(b)
- Sherry LiuDirector
- Joaquin GarciaDirector
- Robert StalloneDirector
- Partha MitraDirector
- Eric FeinsteinExecutive Officer, Director
- Laurence KraemerDirector
- Charles CantorDirector
- Michael ShelanksiDirector
- Offering amount
- $40M
- Amount sold
- $36M
- First sale
- Mar 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$4.2MraisedDec 2019 · 5 investors · Other Health CareRule 506(b)
- Partha MitraDirector
- Michael ShelanskiDirector
- Robert StalloneDirector
- Eric FeinsteinExecutive Officer, Director
- Charles CantorDirector
- Offering amount
- $10.4M
- Amount sold
- $4.2M
- First sale
- Nov 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Company profile
researched Aug 2026Clarapath is a healthcare robotics company focused on laboratory medicine and histopathology workflows. Its product, SectionStar, is a benchtop automated tissue sectioning system that uses custom-engineered robotics and precision motion controls to replicate the manual skills of a histotechnician, producing microscope slides from tissue blocks. The system handles up to 72 blocks and 200 slides per session, supports user-defined sectioning thickness from 3 to 10 microns, and is designed for continuous 24x7x365 operation.
The platform combines patented environmental and quality control subsystems, integrated optics and sensors, and a patented tape transfer method for section handling, which the company states avoids the artifacts, distortions and cross-contamination associated with traditional waterbath techniques. Software provides a web-based user interface, including a remote "Telehistology" capability that allows a histotechnician in one location to operate one or more SectionStar systems elsewhere. The company states that systems are built, assembled and serviced in the United States.
Business model
Clarapath supplies automated sectioning instrumentation and accompanying software to laboratories, with servicing provided by the company.
▸Full profile — market position, technology, go-to-market, geography
Market position
Clarapath positions itself in laboratory automation for histopathology, addressing slide quality, turnaround time and cost in tissue sectioning.
The system is positioned around standardized slide quality via tape transfer sections free of waterbath artifacts and cross contamination, a benchtop footprint, continuous run time, and remote operation of multiple systems by a single histotechnician.
Technology
Custom-engineered robotics with precision motion controls drive dozens of subsystems that automate tissue sectioning. The system incorporates patented environmental and quality control systems, integrated optics and sensors, and a patented tape transfer approach to section handling. Software supports navigation of daily lab tasks and web-based remote operation of multiple systems (Remote Telehistology).
Go-to-market
Direct engagement with laboratories through information requests on the company website, targeting clinical, veterinary and research/drug development labs.
Histology and pathology laboratories across human clinical healthcare, animal healthcare, and research and drug development settings.
Geography
Headquartered in Hawthorne, United States; systems are built, assembled and serviced in the USA, with remote operation supported across locations.
Compiled by commissioned research from 1 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
Legal entities · 1
corporate structureIn the news
▸Research sources · 1
primary sources listed
- Clarapathclarapath.com · web
1 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Clarapath do?
- Clarapath builds SectionStar, a benchtop robotic system that automates tissue sectioning and slide creation for histology labs.
- Who are Clarapath's investors?
- Clarapath's investors include East Post Road Ventures, Evolution VC Partners, P5 Health Ventures.
- How much funding has Clarapath raised?
- Clarapath has disclosed $40.2M raised across 2 of its 5 known rounds.
- Where is Clarapath headquartered?
- Clarapath is headquartered in Hawthorne, US.